[1]
|
Tabas, I. (2002) Cholesterol in health and disease. The Journal of Clinical Investigation, 110, 583-590.
|
[2]
|
Myant, N.B. (1990) Current approaches to the genetics of coronary heart disease (CHD) including an account of work done at Hammersmith Hospital. Bollettino della Società italiana di biologia sperimentale, 66, 1015-1041.
|
[3]
|
Jiang, J.H., Kai, G.Y., Cao, X.Y., Chen, F.M., He, D.N. and Liu, Q. (2006) Molecular clon-ing of a HMG-CoA reductase gene from eucommia ulmoides oliver. Bioscience Reports, 26, 171-181.
doi:10.1007/s10540-006-9010-3
|
[4]
|
Sato, K., Ohuchi, A., Sook, S.H., Toyomizu, M. and Akiba, Y. (2003) Changes in mRNA expression of 3-hydroxy-3-methylglutaryl coenzyme A reductase and cholesterol 7 alpha-hydroxylase in chickens. Biochimica Biophysica Acta, 1630, 96-102.
|
[5]
|
Agriculture industrial standard of the People’s Republic (NY/T1180-2006). The measuring method of muscle tender and shear force. Min-istry of Agriculture of the People’s Republic.
|
[6]
|
Humphries, S.E., Tata, F., Henry, I., Barichard, F., Holm, M., Junien, C. and Williamson, R. (1985) The isolation, characterization, and chromosomal assignment of the gene for human hydroxyl 3-methylglutaryl coenzyme A reductase (HMG-CoA reductase). Human Genetics, 71, 254-258. doi:10.1007/BF00284585
|
[7]
|
Wang, X.F. (2006) Molecular cloning, expression analysis, chromosome mapping and poly-morphism analysis of porcine HMGR gene. PhD Thsis, China Agricultural University.
|
[8]
|
Sundaresan, S., Yang-Feng, T.L. and Francke, U. (1989) Genes for HMG-CoA reductase and serotonin 1a receptor are on mouse chromosome 13. Somatic Cell and Molecular Genetics, 15, 465-469. doi:10.1007/BF01534897
|
[9]
|
Goldwasser, J., Cohen, P.Y., Yang, E., Balaguer, P., Yarmush, M.L. and Nahmias, Y. (2010) Transcriptional regulation of human and rat hepatic lipid meta-bolism by the grapefruit flavonoid naringenin: Role of PPARα, PPARγ, and LXRα. PLoS One, 5, e12399.
doi:10.1371/journal.pone.0012399
|
[10]
|
Tobert, J.A. (2003) Lovastatin and beyond: The history of the HMG-CoA reductase inhibitors. Nature Reviews Drug Discovery, 2, 517-526. doi:10.1038/nrd1112
|
[11]
|
Ness, G.C. (2003) Physiological and pharmacological regulation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase. Current Medicinal Chemistry-Imu- nology, Endocrine & Metabolic Agents, 3, 219-227.
doi:10.2174/1568013033483366
|
[12]
|
Rasmusseen, L.M., Hanzen, P.R., Nabipour, M.T., Olesen, P., Kristiansen, M.T. and Ledet, T. (2001) Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells. The Biochemical Journal, 360, 363-370.
doi:10.1042/0264-6021:3600363
|